The Copley Consulting Group was honored to have recently received the Channelnomics 2018 Innovation Award in the area of Industry Achievement. This award recognizes an investment of resources into our FDA Regulated solution for Infor CloudSuite Industrial ERP. This has resulted in rapid growth for the company and several recent customer wins, including Femasys, Blickman Industries and Pine Pharmaceuticals.
The company’s growth this year is attributed to continued successes in micro-vertical markets, including Medical Device, Pharmaceutical and other FDA regulated markets. Developed by The Copley Consulting Group, the Infor CloudSuite Industrial ERP for Life Sciences and Medical Devices solution delivers advanced security, data auditability, electronic recording, and business intelligence capabilities mandated for FDA compliance. Copley saw a 65% growth in 2017 from FDA regulated business and that market represented 38% of our overall business.
Customers such as Blickman Industries, a manufacturer of stainless steel and chrome products for the healthcare market, turned to Copley to transform their business manual processes to an automated workflow. Anthony Lorenzo, Chief Executive Officer of Blickman Industries, said “With Infor and Copley, we feel we have the right partners in place to help us integrate engineering with production, while providing us with analytical insights to help enhance quality, lower pricing, enable faster product delivery, and improve overall customer service.”
Copley was also recently honored by Infor as their Partner of the Year with the distinction of having secured the highest volume of net new business in North America. This is the sixth time in seven years that Copley has been recognized for our achievements as part of Infor’s Channel organization.
Read more about this most recent honor and the momentum realized by Copley Consulting in this Q&A with CEO Robert Lane posted to Channelnomics. Please contact us if we can assist as you transform your business to meet compliance regulations.
Share this on Social:
